Locations:
Search IconSearch
April 18, 2022/Neurosciences/Podcast

Use of Ketamine to Treat Chronic Pain (Podcast)

IV ketamine infusion is an option when conventional therapies fail to yield relief


Approximately 20% of U.S. adults experience chronic pain, according to the Centers for Disease Control and Prevention. During the past two decades, intravenous ketamine infusion has gained popularity as a treatment option for patients with the most refractory cases.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“If a patient has tried conventional treatments — such as medications, injections, surgery, pain psychology, pain rehabilitation programs — and their pain persists, then ketamine may be a good option,” says Pavan Tankha, DO, an anesthesiologist and pain management physician who serves as Medical Director of the Center for Comprehensive Pain Recovery in Cleveland Clinic’s Neurological Institute.

In the most recent episode of Cleveland Clinic’s Neuro Pathways podcast, Dr. Tankha talks about the use of ketamine to manage refractory chronic pain. He delves into:

  • The history of ketamine and how it became a pain management treatment
  • Patient selection and administration of ketamine infusion
  • Contraindications and potential side effects
  • The risk of addiction to ketamine
  • What constitutes a positive response to treatment

Click the podcast player above to listen to the 25-minute episode now, or read on for a short edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

This activity has been approved for AMA PRA Category 1 Credit™. After listening to the podcast, you can claim your credit here.

Excerpt from the episode

Podcast host Glen Stevens, DO, PhD: Are there certain chronic pain conditions for which ketamine works better than for others?

Dr. Tankha: Very good question. So, the literature for ketamine and pain is somewhat limited. Because of that, if you go based on simply the literature, the most extensively studied pain state is complex regional pain syndrome, where ketamine has been shown to have a modest benefit. Other neuropathic pain states, such as phantom limb and spinal cord injury, have some data to suggest it may work. Nociceptive pain pathways, such as osteoarthritis and rheumatoid arthritis, have limited to no data.

Advertisement

Anecdotally, based on my own experience, I’ve found that ketamine can potentially help with these conditions, but because we don’t really understand how it works, we can’t choose the appropriate candidates all the time. But given its good safety profile, I recommend giving it a try if you have exhausted other methods.

Dr. Stevens: When you give ketamine, where do you do it? What is the administration like?

Dr. Tankha: We are fortunate to have the capabilities on Cleveland Clinic’s main campus [in an infusion suite]. … It is done over a five-day period, Monday through Friday. You come in, we start an IV and we run the ketamine through your bloodstream for approximately 40 minutes. At the end of the infusion, we give you some fluids just to wash it out of your system. And then you can go home. Because ketamine is a general anesthetic, you need someone to take you back home. Some patients get a little loopy, some patients don’t feel anything. But just to be on the safe side, we ask that someone take the patient home.

Advertisement

Related Articles

William Clifton, MD, against a decorative background
November 4, 2024/Neurosciences/Podcast
Adult Idiopathic Scoliosis: Essentials of Diagnosis and Treatment (Podcast)

Early intervention yields the best outcomes, but surgery can benefit older patients as well

Creative illustration of a brain
October 16, 2024/Neurosciences/Podcast
Diagnosing Atypical Parkinsonian Disorders (Podcast)

Patient history plays a key role in identifying the condition

dr. daniel ontaneda against a decorative background
October 2, 2024/Neurosciences/Podcast
Takeaways From the New Diagnostic Criteria for Multiple Sclerosis (Podcast)

A co-author explains some of the key McDonald criteria revisions

Dr. Imad Najm against a decorative background
September 16, 2024/Neurosciences/Podcast
Temporal Lobe Epilepsy and the Potential of Gene Therapy (Podcast)

Investigational gene approaches offer hope for a therapeutically challenging condition

alison stout, DO, against a decorative backdrop
August 9, 2024/Neurosciences/Podcast
Evaluation and Interventional Treatment of Axial Lumbar Back Pain (Podcast)

This common condition remains tough to work up and diagnose, and treatment options are limited

Dr. Amy Kunchok against decorative background
July 16, 2024/Neurosciences/Podcast
What to Know About Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) (Podcast)

It’s time to get familiar with this emerging demyelinating disorder

receptor activity for myasthenia gravis medications
July 3, 2024/Neurosciences/Podcast
Myasthenia Gravis: Unmet Needs and Efforts to Address Them (Podcast)

An overview of associated antibodies, therapies for antibody-positive disease and the outlook for atypical forms of MG

adult female figure suffering headache
June 17, 2024/Neurosciences/Podcast
Migraine Relief: Providing Preventive and Abortive Therapies (Podcast)

A close look at the growing array of options for episodic and chronic migraine

Ad